|4Jan 3, 6:12 PM ET

CVS CAREMARK CORP 4

4 · CVS CAREMARK CORP · Filed Jan 3, 2014

Insider Transaction Report

Form 4
Period: 2014-01-02
Lofberg Per GH
President, Caremark Pharm Serv
Transactions
  • Exercise/Conversion

    Stock Option

    2014-01-03234,0660 total
    Exercise: $34.96From: 2012-12-31Exp: 2018-04-01Common Stock (234,066 underlying)
  • Exercise/Conversion

    Stock Option

    2014-01-02401,70653,124 total
    Exercise: $32.98From: 2012-12-31Exp: 2020-01-03Common Stock (401,706 underlying)
  • Award

    Stock Option

    2014-01-02$70.40/sh+112,181$7,897,542112,181 total
    Exercise: $70.40From: 2014-12-31Exp: 2021-01-02Common Stock (112,181 underlying)
  • Exercise/Conversion

    Common Stock

    2014-01-03$34.96/sh+234,066$8,182,947280,466 total
  • Exercise/Conversion

    Stock Option

    2014-01-03101,9920 total
    Exercise: $36.23From: 2011-04-01Exp: 2017-04-01Common Stock (101,992 underlying)
  • Sale

    Common Stock

    2014-01-03$70.61/sh53,124$3,751,08646,400 total
  • Exercise/Conversion

    Stock Option

    2014-01-0353,1240 total
    Exercise: $32.98From: 2012-12-31Exp: 2020-01-03Common Stock (53,124 underlying)
  • Exercise/Conversion

    Common Stock

    2014-01-02$32.98/sh+401,706$13,248,264448,106 total
  • Sale

    Common Stock

    2014-01-02$70.58/sh401,706$28,352,40946,400 total
  • Sale

    Common Stock

    2014-01-03$70.47/sh234,066$16,494,63146,400 total
  • Sale

    Common Stock

    2014-01-03$70.47/sh101,992$7,187,37646,400 total
  • Exercise/Conversion

    Common Stock

    2014-01-03$36.23/sh+101,992$3,695,170148,392 total
  • Exercise/Conversion

    Common Stock

    2014-01-03$32.98/sh+53,124$1,752,03099,524 total
Holdings
  • Common Stock

    (indirect: By Partnership)
    162,000
  • Stock Unit

    219,870.588
  • Stock Option

    Exercise: $45.07From: 2013-12-31Exp: 2019-12-31Common Stock (347,343 underlying)
    347,343
  • Common Stock

    (indirect: By Trust)
    14,400
Footnotes (10)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F10]Option became exercisable on December 31, 2013.
  • [F2]Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share.
  • [F3]Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share.
  • [F4]Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share.
  • [F5]Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.43 and $70.75 per share.
  • [F6]Option became exercisable on 12/31/2012.
  • [F7]Option becomes exercisable on December 31, 2014.
  • [F8]Option became exercisable on 12/31/2012.
  • [F9]The Option becomes exercisable in three equal installments on April 1, 2011, April 1, 2012 and April 1, 2013, provided, however, that if the reporting person remains employed through December 31, 2012, then the option shall become exercisable in full as of December 31, 2012, and shall remain exercisable for one year following the reporting person's last date of employment with the Company.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT